The goal of this presentation is to advance one's individual knowledge of Barrett's esophagus. Barrett's is a condition that develops in some people that experience chronic gastroesophageal reflux disease (GERD) or esophagitis. After reflux-induced damage to the normal, squamous, cells of the esophagus, regenerating cells undergo a metaplastic transformation to abnormal intestinal-type columnar cells. Barrett's esophagus is this premalignant condition. Barrett's cells may eventually progress into dysplasia, which over time can advance to low grade dysplasia, then high grade dysplasia, and finally, adenocarcinoma of the esophagus. Barrett's esophagus is diagnosed through tissue sample obtained via endoscopy. There is no proven way to prevent Barrett's esophagus; however, studies show that treating GERD may slow the disease process and prevent complications. Once Barrett's is diagnosed, endoscopic surveillance is often performed and measures are taken to minimize acid exposure to the esophagus. If a patient reaches high grade dysplasia or carcinoma, they must then decide between 4 possible options: 1) do nothing, 2) surgical esophagectomy, 3) endoscopic mucosal resection (EMR) of the involved area, or 4) photodynamic therapy (PDT). All options may not be suitable for all patient situations. This complex disease will be discussed in detail, along with its various contributing factors.

Section Description

We are pleased to present the abstracts from SGNA's 33rd Annual Course, SGNA on a Mission: Exceeding Expectations. The diversity of these topics certainly reflects the richness and breadth of our specialty. In keeping with the tradition of the Annual Course, we hope the following abstracts will encourage discussions for improving nursing practice and patient care outcomes.